Indeed, several of the IRF8/MEF2D direct target genes, such as MYC, HOXA9, and ZEB2, are highly expressed and essential in non-KMT2Ar leukemias and normal hematopoietic progenitors that do not express high levels of IRF8/MEF2D. This evidence concerns the gene MYC and leukemia.